These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
164 related items for PubMed ID: 38569430
1. Extracellular vesicles derived from plasmodium-infected red blood cells alleviate cerebral malaria in plasmodium berghei ANKA-infected C57BL/6J mice. Lv Y, Wu S, Nie Q, Liu S, Xu W, Chen G, Du Y, Chen J. Int Immunopharmacol; 2024 May 10; 132():111982. PubMed ID: 38569430 [Abstract] [Full Text] [Related]
2. Induction of pro-inflammatory mediators in Plasmodium berghei infected BALB/c mice breaks blood-brain-barrier and leads to cerebral malaria in an IL-12 dependent manner. Schmidt KE, Schumak B, Specht S, Dubben B, Limmer A, Hoerauf A. Microbes Infect; 2011 Sep 10; 13(10):828-36. PubMed ID: 21609776 [Abstract] [Full Text] [Related]
3. A single injection of 19 kda carboxy-terminal fragment of Plasmodium yoelii merozoite surface protein 1 (PyMSP1(19)) formulated with Montanide ISA and CpG ODN induces protective immune response in mice. Hirunpetcharat C, Mahakunkijcharoen Y, Jeamwattanalert P, Kittigul L, Mahannop P, Pichyangkul S. Asian Pac J Allergy Immunol; 2011 Sep 10; 29(3):252-9. PubMed ID: 22053595 [Abstract] [Full Text] [Related]
4. Neuroimmunological blood brain barrier opening in experimental cerebral malaria. Nacer A, Movila A, Baer K, Mikolajczak SA, Kappe SH, Frevert U. PLoS Pathog; 2012 Sep 10; 8(10):e1002982. PubMed ID: 23133375 [Abstract] [Full Text] [Related]
5. Differential role of T regulatory and Th17 in Swiss mice infected with Plasmodium berghei ANKA and Plasmodium yoelii. Keswani T, Bhattacharyya A. Exp Parasitol; 2014 Jun 10; 141():82-92. PubMed ID: 24675415 [Abstract] [Full Text] [Related]
6. Oral Therapy Using a Combination of Nanotized Antimalarials and Immunomodulatory Molecules Reduces Inflammation and Prevents Parasite Induced Pathology in the Brain and Spleen of P. berghei ANKA Infected C57BL/6 Mice. Mukherjee S, Ray G, Saha B, Kar SK. Front Immunol; 2021 Jun 10; 12():819469. PubMed ID: 35095923 [Abstract] [Full Text] [Related]
7. Long-lasting protective immune response to the 19-kilodalton carboxy-terminal fragment of Plasmodium yoelii merozoite surface protein 1 in mice. Jeamwattanalert P, Mahakunkijcharoen Y, Kittigul L, Mahannop P, Pichyangkul S, Hirunpetcharat C. Clin Vaccine Immunol; 2007 Apr 10; 14(4):342-7. PubMed ID: 17314232 [Abstract] [Full Text] [Related]
8. Estradiol, but not dehydroepiandrosterone, decreases parasitemia and increases the incidence of cerebral malaria and the mortality in plasmodium berghei ANKA-infected CBA mice. Libonati RM, Cunha MG, Souza JM, Santos MV, Oliveira SG, Daniel-Ribeiro CT, Carvalho LJ, do Nascimento JL. Neuroimmunomodulation; 2006 Apr 10; 13(1):28-35. PubMed ID: 16699290 [Abstract] [Full Text] [Related]
9. [Immune characteristics of Plasmodium reinfections in mice following chloroquine cure of primary Plasmodium infections]. Wang Y, Yao X, Tang MY, Liu L, Song SH, Tao ZY, Xia H, Chang XL, Fang Q. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2020 Nov 23; 32(6):569-576. PubMed ID: 33325190 [Abstract] [Full Text] [Related]
10. Parasite densities modulate susceptibility of mice to cerebral malaria during co-infection with Schistosoma japonicum and Plasmodium berghei. Wang ML, Feng YH, Pang W, Qi ZM, Zhang Y, Guo YJ, Luo EJ, Cao YM. Malar J; 2014 Mar 26; 13():116. PubMed ID: 24670210 [Abstract] [Full Text] [Related]
12. CpG oligodeoxynucleotide and Montanide ISA 51 adjuvant combination enhanced the protective efficacy of a subunit malaria vaccine. Kumar S, Jones TR, Oakley MS, Zheng H, Kuppusamy SP, Taye A, Krieg AM, Stowers AW, Kaslow DC, Hoffman SL. Infect Immun; 2004 Feb 26; 72(2):949-57. PubMed ID: 14742540 [Abstract] [Full Text] [Related]
13. A blood stage fraction of Plasmodium berghei induces protective and long lasting immune response in BALB/c mice. Bagai U, Pawar A. Parasitol Int; 2013 Jun 26; 62(3):329-36. PubMed ID: 23085043 [Abstract] [Full Text] [Related]
14. Prevention of experimental cerebral malaria by Flt3 ligand during infection with Plasmodium berghei ANKA. Tamura T, Kimura K, Yuda M, Yui K. Infect Immun; 2011 Oct 26; 79(10):3947-56. PubMed ID: 21807908 [Abstract] [Full Text] [Related]
15. Doxycycline inhibits experimental cerebral malaria by reducing inflammatory immune reactions and tissue-degrading mediators. Schmidt KE, Kuepper JM, Schumak B, Alferink J, Hofmann A, Howland SW, Rénia L, Limmer A, Specht S, Hoerauf A. PLoS One; 2018 Oct 26; 13(2):e0192717. PubMed ID: 29438386 [Abstract] [Full Text] [Related]
16. Defining rules of CD8(+) T cell expansion against pre-erythrocytic Plasmodium antigens in sporozoite-immunized mice. Billman ZP, Kas A, Stone BC, Murphy SC. Malar J; 2016 Apr 26; 15():238. PubMed ID: 27113469 [Abstract] [Full Text] [Related]
17. Eosinophils Suppress the Migration of T Cells Into the Brain of Plasmodium berghei-Infected Ifnar1-/- Mice and Protect Them From Experimental Cerebral Malaria. Scheunemann JF, Reichwald JJ, Korir PJ, Kuehlwein JM, Jenster LM, Hammerschmidt-Kamper C, Lewis MD, Klocke K, Borsche M, Schwendt KE, Soun C, Thiebes S, Limmer A, Engel DR, Mueller AK, Hoerauf A, Hübner MP, Schumak B. Front Immunol; 2021 Apr 26; 12():711876. PubMed ID: 34659202 [Abstract] [Full Text] [Related]
19. Pre-existing Schistosoma japonicum infection alters the immune response to Plasmodium berghei infection in C57BL/6 mice. Wang ML, Cao YM, Luo EJ, Zhang Y, Guo YJ. Malar J; 2013 Sep 14; 12():322. PubMed ID: 24034228 [Abstract] [Full Text] [Related]
20. Rate of red blood cell destruction varies in different strains of mice infected with Plasmodium berghei-ANKA after chronic exposure. Helegbe GK, Huy NT, Yanagi T, Shuaibu MN, Yamazaki A, Kikuchi M, Yasunami M, Hirayama K. Malar J; 2009 May 05; 8():91. PubMed ID: 19416511 [Abstract] [Full Text] [Related] Page: [Next] [New Search]